Over the Counter (OTC) stocks are generally categorized as risky investments because of the lack of public information and transparency and the fact that there are no minimum listing standards for these exchanges. But the OTC market is also brimming with legitimate companies backed by a management team with the experience and determination to advance the company’s development and achieve considerable growth.
Every the greatest companies had a beginning, and the majority of them had a modest one. The most powerful companies on the planet started as a mere idea, a plow-horse if you will, steered by the hand of innovative individuals willing to identify and use the resources necessary to bring this idea to fruition.
Inherent with a powerful growth strategy is visibility and liquidity, and for this reason many OTC stocks seek to “graduate” to a major exchange. According to a recent NASDAQ study, companies upgrading to the NASDAQ within three months see their average daily volume more than double. The uplisting also provides a company with regulatory oversight, inclusion to indexes such as the NASDAQ and S&P, and a greater opportunity to receive analyst coverage.
To execute this uplisting, a company must meet numerous listing requirements. And the payoff is an introduction to the opportunity to greater value for both the company and its shareholders.
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Two MissionIR clients this week were upgraded to the NASDAQ exchange, reflecting persistent and diligent work of well-seasoned management teams and staff, and an overarching and powerful desire for company growth. On October 17, ForceField Energy, Inc. (FNRG) and Advaxis, Inc. (ADXS) both made their NASDAQ debut.
FNRG, an international manufacturer, distributor, and licensee of alternative energy products in solutions operates through two primary segments of the renewable energy market: industrial waste heat recovery and conversion, and commercial LED lighting products. For more information visit www.ForceFieldEnergy.com.
ADXS is a clinical-stage biotech company focused on developing next-generation immunotherapies for cancer and infectious disease. The company has more than 15 distinct constructs in various stages of development. For more information visit www.Advaxis.com.
The transition of these companies’ stock to the NASDAQ from the OTC system creates the chance for greater visibility, increased liquidity, and exposure to analysts and institutional investors. MissionIR applauds this achievement and the opportunity to broaden each company’s influence, market reach, and investment pool.
For more information on MissionIR, visit www.MissionIR.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
